Lv1
65 积分 2021-04-02 加入
Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3
1天前
求助中
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
3天前
已完结
One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study
10天前
已完结
Screening for Lung Cancer
10天前
已完结
Identifying patients who benefit more from perioperative immunotherapy combinations for resectable non-small cell lung cancer based on clinical and molecular characteristics: a meta-analysis of randomized clinical trials
16天前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
29天前
已完结
Pembrolizumab for advanced non-small cell lung cancer (NSCLC): Impact of autoimmune comorbidity and outcomes following treatment completion
1个月前
已完结
Surgical Strategies for Pre- and Minimally Invasive Lung Adenocarcinoma 3.0: Lessons Learned From the Optimal Timing of Surgical Intervention
1个月前
已完结
Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer
1个月前
已完结
Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer
1个月前
已完结
皖公网安备34019202002308
